Axepron Adverse Reactions

Postmarketing Experience: The following adverse reactions have been identified during post approval use of pantoprazole. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a casual relationship to drug exposure.
These adverse reactions are listed as follows by body system: General Disorders and Administration Conditions: Asthenia, fatigue, malaise.
Immune System Disorders: Anaphylaxis (including anaphylactic shock).
Investigations: Weight changes.
Skin and Subcutaneous Tissue Disorders: Severe dermatologic reactions (some fatal), including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis (TEN), and angioedema (Quincke's edema).
Muscoskeletal Disorders: Rhabdomyolysis, bone fracture.
Renal and Urinary Disorders: Interstitial nephritis.
Hepatobiliary Disorders: Hepatocellular damage leading to jaundice and hepatic failure.
Psychiatric Disorder: Hallucinations, confusion, insomnia, somnolence.
Metabolism and Nutritional Disorders: Hyponatremia, hypomagnesemia.
Infections and Infestations: Clostridium difficile associated diarrhea.
Hematologic: Pancytopenia, agranulocytosis.
Nervous: Ageusia, dysgeusia.